ADMA, subclinical changes and atrial fibrillation in the general population.

[1]  Y. Okumura,et al.  Increased levels of inflammatory and extracellular matrix turnover biomarkers persist despite reverse atrial structural remodeling during the first year after atrial fibrillation ablation , 2014, Journal of Interventional Cardiac Electrophysiology.

[2]  T. Chao,et al.  Plasma Asymmetric Dimethylarginine and Adverse Events in Patients with Atrial Fibrillation Referred for Coronary Angiogram , 2013, PloS one.

[3]  W. Bauman,et al.  Acute nitric oxide synthase inhibition and cardiac conduction in persons with spinal cord injury: a short report. , 2013, Die Pharmazie.

[4]  P. Sanders,et al.  Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. , 2013, Journal of the American College of Cardiology.

[5]  Shing‐Jong Lin,et al.  Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure. , 2012, Atherosclerosis.

[6]  N. Frey,et al.  The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy. , 2012, Journal of cardiac failure.

[7]  N. McMahon,et al.  Comparison of non-invasive and implanted telemetric measurement of blood pressure and electrocardiogram in conscious beagle dogs. , 2012, Journal of pharmacological and toxicological methods.

[8]  A. Goette,et al.  Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation , 2012, Front. Physio..

[9]  A. Melidonis,et al.  Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure , 2012, Heart.

[10]  A. Goette,et al.  The impact of rapid atrial pacing on ADMA and endothelial NOS. , 2012, International journal of cardiology.

[11]  V. Gudnason,et al.  Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  Josef Coresh,et al.  Chronic Kidney Disease Is Associated With the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study , 2011, Circulation.

[13]  D. Levy,et al.  P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study). , 2011, The American journal of cardiology.

[14]  Michael J Pencina,et al.  Validation of an atrial fibrillation risk algorithm in whites and African Americans. , 2010, Archives of internal medicine.

[15]  Jeroen J. Bax,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  D. Levy,et al.  Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the Community , 2010, Circulation.

[17]  E. Bloemena,et al.  Low arginine/asymmetric dimethylarginine ratio deteriorates systemic hemodynamics and organ blood flow in a rat model , 2009, Critical care medicine.

[18]  E. Benjamin,et al.  Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample. , 2009, Atherosclerosis.

[19]  S. Hazen,et al.  Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure. , 2008, European heart journal.

[20]  S. Nattel,et al.  Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[21]  D. Luo,et al.  Reduction of asymmetric dimethylarginine involved in the cardioprotective effect of losartan in spontaneously hypertensive rats. , 2007, Canadian journal of physiology and pharmacology.

[22]  E. Schwedhelm,et al.  High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[23]  Thomas Weber,et al.  Arterial wave reflections and determinants of endothelial function a hypothesis based on peripheral mode of action. , 2007, American journal of hypertension.

[24]  M. Guazzi,et al.  Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats. , 2007, European journal of pharmacology.

[25]  D. Levy,et al.  Pulse pressure and risk of new-onset atrial fibrillation. , 2007, JAMA.

[26]  Frank Donnerstag,et al.  ADMA Increases Arterial Stiffness and Decreases Cerebral Blood Flow in Humans , 2006, Stroke.

[27]  T. Münzel,et al.  ADMA and oxidative stress. , 2003, Atherosclerosis. Supplements.

[28]  K. Channon,et al.  A Myocardial Nox2 Containing NAD(P)H Oxidase Contributes to Oxidative Stress in Human Atrial Fibrillation , 2003, Circulation research.

[29]  P. Vallance,et al.  Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[30]  J. Murabito,et al.  Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality The Framingham Heart Study , 2003, Circulation.

[31]  H. Struijker‐Boudier,et al.  Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases , 2003, Circulation.

[32]  Joao A. C. Lima,et al.  Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. , 2002 .

[33]  C. Zoccali,et al.  Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study , 2001, The Lancet.

[34]  M. Chung,et al.  Ascorbate Attenuates Atrial Pacing-Induced Peroxynitrite Formation and Electrical Remodeling and Decreases the Incidence of Postoperative Atrial Fibrillation , 2001, Circulation research.

[35]  D. V. Van Wagoner,et al.  Impaired Myofibrillar Energetics and Oxidative Injury During Human Atrial Fibrillation , 2001, Circulation.

[36]  D. Levy,et al.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.

[37]  S. Moncada,et al.  Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure , 1992, The Lancet.

[38]  H. Crijns,et al.  Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[39]  I. Shapira,et al.  Electromechanical impairment of human auricle and rat myocardial strip subjected to exogenous oxidative stress. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[40]  Joao A. C. Lima,et al.  Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms , 2002, Nature.